StemCells Inc. Reports Fourth Quarter and Fiscal 2010 Financial Results and Business Highlights
PALO ALTO, Calif., March 11, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, today reported financial results for the fourth quarter and year ended December 31, 2010 and recent business highlights.